RELATED CONTENT
NEWS
- ASLAN gains global rights to Almirall's DHODH inhibitor for rheumatoid arthritis
- Cancer developer Merrimack dives into a tough IPO pool with a $172M filing
- AVEO's unconvincing Phase II ficlatuzumab data point to need for further studies
- Array trims research staff by 20%, backing off some early-stage R&D
ANALYSIS
Other Informa Analysis
EVENTS
Today
Continental Zara Hotel, Budapest, Hungary
Today
Radisson Blu Royal Hotel, Dublin
Today
Hotel Sofitel Hamburg Alter Wall
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

